Search
Sumario de resultados
TIpos de contenido
Fecha
-
Press releaseUsing cardio-metabolomic diagnosis to reduce the consequences of obesity
Biotech company OWL Metabolomics develops non-invasive, early diagnosis products for obesity-related diseases
-
NewSpain leads research in advanced therapies with almost 120 clinical trials
Spain is positioned as a leader and benchmark country in advanced therapies, the cornerstone for the treatment of diseases such as cancer, where 62% of clinical trials are conducted.
-
Press releaseORYZON starts preclinical collaboration on autism with the Seaver Autism Center at Mount ...
Goal is to explore effects of LSD1 inhibition on animal models of autism in Shank3 deficient mice models
-
-
Press releaseOur researcher in oncology, Gema Malet, receives a Marie Skłodowska-Curie research grant
In 2020, biologist Gema Malet Engra joined the biotechnology company Laminar Pharmaceuticals after a successful 15-year career in fundamental and applied research in Oncology at several international
-
TeamHonorary members
-
-
-
Press releaseORYZON enrolls first patient in PORTICO
PORTICO is a Phase IIb clinical trial with vafidemstat in Borderline Personality Disorder recruiting patients in Europe and the U.S and dedicated to independent assessment of reduction of agitation
-
-
Press releaseIUL launches iPeak+, the new lateral flow reader for rapid tests
IUL SA launches iPeak+, a new colorimetric off-the-shelf lateral flow reader designed to hold large cassettes. This portable reader is equipped with connectivity and it is able to read cassettes of up
-
Press releaseORYZON publishes vafidemstat first-in-human clinical trial manuscript in CNS Drugs journa...
Vafidemstat displayed good safety and tolerability in healthy young and elderly volunteers
-
Press releaseORYZON to participate in upcoming virtual international conferences in March and April
The company will attend to BIO-Europe Spring 2021, Kempen Life Sciences Conference and the 4 th SACHS Annual Neuroscience Innovation Forum 2021
-
Press releaseORYZON announces successful pre-IND meeting with FDA for the clinical development of vafi...
Oryzon will consequently proceed to file an IND application PORTICO will be developed in several US and European sites
-
NewHow the spanish biotechnology is fighting COVID-19
The Spanish Association of Biotechnological Companies (AseBio) gathers the work of its partners in a year of pandemic. At least 64 AseBio partners, such as companies, hospitals, and research centres
-
AllyABG Intellectual Property
ABG IP focuses on industrial property protection (patents, trademarks, designs, etc.). The firm currently has a team of more than 70 professionals at its offices in Madrid, Catalonia, the Basque
-
Press releaseBIOLAN has launched its rapid serological test for the detection of antibodies against COV...
The Basque SME located in Zamudio has invested heavily to equip itself with the equipment that will allow it to scale up the newly developed product
-
-
EventBioEurope
-
Logo Progenie Molecular
CompanyProgenie molecular S.L.U
-
CompanyWacker León SLU